- NCIt
- C8101
Loading cancer entity…
Loading cancer entity…
Clinical trials
1,164 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00009932 | Combination Chemotherapy in Treating Patients With Solid Tumors | unknown | Phase 1 | — | Ohio State University Comprehensive Cancer CenterOTHER | 1 | May 15, 2013 | clinicaltrials |
| NCT00550927 | Enzastaurin and Bevacizumab in Treating Patients With Locally Advanced or Metastatic Cancer | completed | Phase 1 | 42 | Eli Lilly and CompanyINDUSTRY | 1 | May 15, 2013 | clinicaltrials |
| NCT01005693 |
| Screening Tools to Predict Treatment Outcome in Older Cancer Patients Who Are Undergoing Treatment |
| unknown |
| N/A |
| 300 |
| Ziekenhuis Netwerk Antwerpen (ZNA)OTHER |
| 1 |
| May 15, 2013 |
| clinicaltrials |
| NCT00060255 | High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors | completed | Phase 2 | 451 | Roswell Park Cancer InstituteOTHER | 1 | May 9, 2013 | clinicaltrials |
| NCT00112476 | Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | May 3, 2013 | clinicaltrials |
| NCT00287833 | Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Healthy Men | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | May 3, 2013 | clinicaltrials |
| NCT00348985 | PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas | completed | Phase 1 | 55 | National Cancer Institute (NCI)NIH | 1 | May 3, 2013 | clinicaltrials |
| NCT01118611 | Aurora B/C Kinase Inhibitor GSK1070916A in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 38 | Cancer Research UKOTHER | 1 | May 1, 2013 | clinicaltrials |
| NCT00003425 | Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect | completed | Phase 1 / Phase 2 | 25 | University of KentuckyOTHER | 1 | Apr 26, 2013 | clinicaltrials |
| NCT00003403 | GPX-100 in Treating Patients With Solid Tumors | completed | Phase 1 | — | Gem PharmaceuticalsINDUSTRY | 1 | Apr 23, 2013 | clinicaltrials |
| NCT00899951 | Studying Fentanyl in Patients With Cancer | terminated | — | 2 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Apr 18, 2013 | clinicaltrials |
| NCT00003109 | Irinotecan Plus Raltitrexed in Treating Patients With Refractory Solid Tumors | completed | Phase 1 | 39 | Fox Chase Cancer CenterOTHER | 1 | Apr 17, 2013 | clinicaltrials |
| NCT00021346 | Carboplatin and Gemcitabine in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 8 | Fox Chase Cancer CenterOTHER | 1 | Apr 17, 2013 | clinicaltrials |
| NCT00003207 | Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced Cancers | completed | Phase 1 | 14 | Washington University School of MedicineOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT00089362 | Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Apr 10, 2013 | clinicaltrials |
| NCT00003925 | Combination Chemotherapy In Treating Patients With Advanced Cancer | completed | Phase 1 | 36 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 8, 2013 | clinicaltrials |
| NCT00253565 | Imatinib Mesylate and Capecitabine in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 25 | Herbert HurwitzOTHER | 1 | Apr 8, 2013 | clinicaltrials |
| NCT00016185 | Flavopiridol and Docetaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 5, 2013 | clinicaltrials |
| NCT00003956 | Combination Chemotherapy in Treating Patients With Advanced Cancer | completed | Phase 1 | 25 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 4, 2013 | clinicaltrials |
| NCT01096407 | Role of Biomarkers in Muscle Pain and Joint Pain in Patients With Solid Tumors Receiving Paclitaxel | terminated | — | 5 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Apr 4, 2013 | clinicaltrials |
| NCT00084643 | GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid Tumors | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Mar 27, 2013 | clinicaltrials |
| NCT00003252 | Amifostine in Treating Patients With Cancer Who Have Neurological Changes Caused by Chemotherapy | completed | Phase 4 | — | Rush North Shore Medical CenterOTHER | 1 | Mar 26, 2013 | clinicaltrials |
| NCT00003406 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer | completed | Phase 1 / Phase 2 | 30 | Cancer Treatment Centers of AmericaOTHER | 1 | Mar 26, 2013 | clinicaltrials |
| NCT00003703 | Chemotherapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Jewish General HospitalOTHER | 1 | Mar 26, 2013 | clinicaltrials |
| NCT00022295 | Phenoxodiol in Treating Patients With Refractory Solid Tumors | completed | Phase 1 | 36 | Kazia Therapeutics LimitedINDUSTRY | 1 | Mar 26, 2013 | clinicaltrials |
| NCT00091052 | Radiation Therapy and Sargramostim in Treating Patients With Advanced Solid Tumors | completed | Phase 1 / Phase 2 | — | Sirius MedicineINDUSTRY | 1 | Mar 26, 2013 | clinicaltrials |
| NCT00521430 | Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease | completed | N/A | 30 | Asan Medical CenterOTHER | 1 | Mar 26, 2013 | clinicaltrials |
| NCT00016354 | Benzoylphenylurea in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 19 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Mar 25, 2013 | clinicaltrials |
| NCT00084812 | Safingol and Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | 43 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 22, 2013 | clinicaltrials |
| NCT00003368 | Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Mar 21, 2013 | clinicaltrials |
| NCT00303797 | Sorafenib and Bortezomib in Treating Patients With Advanced Cancer | completed | Phase 1 | 50 | National Cancer Institute (NCI)NIH | 1 | Mar 19, 2013 | clinicaltrials |
| NCT00014248 | Adenosine Triphosphate in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Mar 18, 2013 | clinicaltrials |
| NCT00003173 | High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors | completed | Phase 2 | 36 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 7, 2013 | clinicaltrials |
| NCT00005994 | Patient Education in Preventing Nausea and Vomiting in Cancer Patients Receiving Chemotherapy | completed | N/A | — | University of RochesterOTHER | 1 | Mar 5, 2013 | clinicaltrials |
| NCT00007917 | Gemcitabine Plus Flavopiridol in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 58 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00003884 | Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone | completed | Phase 3 | 600 | NovartisINDUSTRY | 1 | Feb 21, 2013 | clinicaltrials |
| NCT00823524 | Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer | completed | Phase 1 / Phase 2 | 47 | Asan Medical CenterOTHER | 1 | Feb 20, 2013 | clinicaltrials |
| NCT00002980 | Decitabine in Treating Patients With Melanoma or Other Advanced Cancer | completed | Phase 1 | — | California Cancer ConsortiumNETWORK | 1 | Feb 15, 2013 | clinicaltrials |
| NCT00544284 | Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment | completed | Phase 1 | 25 | City of Hope Medical CenterOTHER | 1 | Feb 15, 2013 | clinicaltrials |
| NCT01101412 | Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies | withdrawn | Phase 1 / Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Feb 15, 2013 | clinicaltrials |
| NCT00002862 | Perillyl Alcohol in Treating Patients With Refractory Cancer | completed | Phase 1 | 25 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00002946 | Penclomedine in Treating Patients With Solid Tumors or Lymphoma | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00003330 | Interleukin-12 in Treating Patients With Advanced Cancer | completed | Phase 1 | 54 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00004189 | Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00004229 | Endostatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00004242 | Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00006221 | BMS-247550 in Treating Patients With Advanced Cancers | completed | Phase 1 | 54 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00003249 | Carboxyamidotriazole and Ketoconazole in Treating Patients With Advanced Cancers | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| NCT00004241 | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
| NCT00025415 | Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2013 | clinicaltrials |
Data updated 23 days agoSource updated May 15, 2013source: clinicaltrials